Skip to main content
OpenTrials
Completed

NCT Number: NCT04527367

Epidemiology and Long-term Outcome of Patients With VHD

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. The aim of the study is analysis the epidemiology and the long-term prognosis among patients with VHD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Valvular Disease Aortic Valve Disease Aortic Valve Stenosis Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Chronic Disease Chronic Kidney Diseases Coronary Artery Disease Coronary Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Heart Diseases Heart Valve Diseases Kidney Diseases Male Urogenital Diseases Mitral Insufficiency and Aortic Stenosis Mitral Stenosis Mitral Valve Insufficiency Mitral Valve Stenosis Myocardial Ischemia Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases Valvular Heart Disease Vascular Diseases Ventricular Outflow Obstruction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital

Bialystok, 15-276, Poland

About this study

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy.

Patients with moderate and severe valvular heart diseases are included into the study. The set of variables subject to interpretation consisted of demographic data, medical history, result of coronary angiography, and type of applied percutaneous and surgical treatment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Valvular heart disease in moderate and severe stages

Exclusion criteria

  • Age < 18 years old

Treatment and study plan

Innovative medical technologies in invasive cardiology and cardiac surgery

Procedure

A follow-up study included the analysis of medical documentation of the Cardiosurgery and the Invasive Cardiology Departments to provided information on the duration and type of procedure performed.

Other names: Percutaneous coronary intervention, Percutaneous aortic valve replacement, Percutaneous interventional mitral regurgitation treatment, Cardiosurgery

Primary outcomes

  1. Death

    Time frame: 3665 days

    All-cause of mortality

Secondary outcomes

  1. MACCE

    Time frame: 3665 days

    Mocardial infarction, stent thrombosis, stroke or transient ischemic attack, urgent revascularization

Sponsors and collaborators

Lead sponsor

Medical University of Bialystok

Other

Registry information

Official study title

Epidemiology and Long-term Prognosis of Patients With Valvular Heart Diseases (BIA-WAD Study)

Acronym: BIA-WAD

Important dates

Study start
2006
Primary completion
2022
Study completion
2022
First posted
Aug 26, 2020
Registry last updated
Jan 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.